Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Report Fourth Quarter and Full Year 2014 Financial Results

MIGDAL HA'EMEQ, Israel, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
February 03, 2015 09:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Favorable Response From the Australian Patent Office

MIGDAL HA'EMEQ, Israel, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients,...
January 20, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Initiates Clinical Study of Vayacog in Mild Cognitive Impairment

MIGDAL HA'EMEQ, Israel, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
January 02, 2015 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces an Extraordinary General Meeting of Shareholders

MIGDAL HA'EMEQ, Israel, Jan. 2, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it will hold an Extraordinary General Meeting of Shareholders on Thursday,...
November 13, 2014 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Third Quarter 2014 Unaudited Financial Results

MIGDAL HA'EMEQ, Israel, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported its financial...
November 11, 2014 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Initiates Clinical Study of Vayarin(R) in Adult ADHD

MIGDAL HA'EMEQ, Israel, Nov. 11, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer, and marketer of innovative bio-active lipid based nutritional ingredients and...
October 30, 2014 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Report Third Quarter Fiscal Year 2014 Financial Results

MIGDAL HA'EMEQ, Israel, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
August 29, 2014 08:11 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces New Hires to Its Senior Management Team

MIGDAL HA'EMEQ, Israel, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has expanded its management team with the appointment of five new hires...
August 19, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces an Annual General Meeting of Shareholders

MIGDAL HA'EMEQ, Israel, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Annual General Meeting of Shareholders on Monday, September...
August 12, 2014 08:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Initiation of a Clinical Study on Autism Spectrum Disorder

MIGDAL HA'EMEQ, Israel, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced the initiation of a...